Reverting immune suppressionto elicit brain metastasis control

About us*

The RISEbrain consortium brings together the highly complementary expertise of 6 teams with inter-sectorial (basic and clinical) and interdisciplinary focus (life sciences, computational sciences, engineering) to tackle the growing societal challenge posed by brain metastases.

Partners*

RISEbrain brings together 6 partners with diverse backgrounds and expertise. Learn more about our team on our website.

Positions available*

We currently have job openings available! If you are interested check out our website for more information on how to apply.

Consortium achievements*

At RISEBrain, each laboratory has achieved significant scientific achievements in their respective fields of study. Visit our website to learn more about our achievements and ongoing research.

Updating cancer research with patient-focused networks

Trends in Cancer

Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma

Journal for Immunotherapy of Cancer

Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer

J Immunother Cancer

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism. 

Monteiro, Miarka et al.
Nature Medicine

STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis

Priego et al.
Nature Medicine (2018)

Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T-cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

Blood

News & Outreach*

Our RISEbrain partners have been published and featured in top media outlets and conferences. Learn more on our website.

30/08/2023

NEWS

Un estudio descubre que los tumores cerebrales ‘hackean’ la comunicación entre neuronas

Telemadrid. Video.

26/06/2023

News

Neurociencia del cáncer: así secuestran los tumores el sistema nervioso para crecer más rápido

El País

Public outreach activities

Closing women’s health inequality gaps

News

Nanotechnology: a portable device against cervical cancer

Grants

EMBO Installation Grant, TUBITAK National Outstanding Researchers Program

Awards

AXA research fund fellowship, ETH postdoctoral fellowship